Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
|
|
Washington Times (12.30.02) - Monday, December 30, 2002
Rajeev Syal, London Sunday Telegraph
The discovery is an embarrassment to British government ministers who have pressured manufacturers to provide the drugs to Africa at no profit. The ministerial pressure culminated in November when Prime Minister Tony Blair pushed through a two-tier pricing system to ensure the supply of cheap drugs to poorer countries. Hundreds of millions of dollars worth of AIDS drugs are being sold at cost to Africa with the understanding that they will not be sold for profit in developing countries.
Investigators working for GlaxoSmithKline discovered in October that millions of dollars worth of Combivir shipped to Africa had been reimported into Europe via France and Belgium. Detectives found that drugs returned from Senegal had been sold by Africa Aids Africa, a Senegalese agency set up by President Abdoulaye Wade and funded by Western governments. AAA head Latife Gueye, who was appointed by Wade, acknowledged selling the drugs to European businessmen but said he did so only because he needed to buy vital equipment. Gueye has been fired and is under police investigation. "This has been a disaster for Senegal's AIDS program," Wade said on Senegalese TV.
A GSK spokesperson said further investigations involving Interpol had been initiated in other African countries. Detectives are also investigating the discovery of more than $15 million in AIDS-related drugs believed to have been smuggled out of South Africa, some of which turned up in London.
021230
AD022511
Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.